Switch to:
More From Other Websites
AVEO (AVEO) Reports Narrower-than-Expected Loss in Q4 Mar 23 2017
AVEO reports 4Q loss Mar 22 2017
AVEO reports 4Q loss Mar 22 2017
AVEO PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 22 2017
AVEO Reports Full Year 2016 Financial Results and Provides Business Update Mar 22 2017
AVEO Announces First Patient Dosed in Phase 1/2 TiNivo Trial of Tivozanib and Opdivo® (nivolumab)... Mar 22 2017
AVEO Pharmaceuticals (AVEO) Q4 Earnings: What's in Store? Mar 06 2017
Aveo Cancer Drug Tivozanib Clears Safety Review Feb 24 2017
AVEO Announces TIVO-3 Passes The First Safety Monitoring Committee Safety Review Feb 23 2017
AVEO Announces Clinical and Regulatory Updates for Tivozanib Feb 09 2017
AVEO to Present at the 19th Annual BIO CEO & Investor Conference Feb 06 2017
AVEO PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Jan 12 2017
AVEO PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement Jan 05 2017
AVEO PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Jan 04 2017
ETFs with exposure to AVEO Pharmaceuticals, Inc. : December 22, 2016 Dec 22 2016
How AVEO Pharmaceuticals, Inc. (AVEO) Stacks Up Against Its Peers? Dec 13 2016
ETFs with exposure to AVEO Pharmaceuticals, Inc. : December 12, 2016 Dec 12 2016
AVEO Partner Submits Response to Questions on Tivozanib Nov 29 2016
AVEO Announces Submission of Responses to the EMA Day 120 List of Questions for Marketing... Nov 28 2016
AVEO to Present at the 28th Annual Piper Jaffray Healthcare Conference Nov 22 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK